UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR

SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-10827

PAR PHARMACEUTICAL COMPANIES, INC.

(Exact name of registrant as specified in its charter)

300 Tice Boulevard

Woodcliff Lake, NJ 07677

(201) 802-4000

(Address, including zip code, and telephone number, including area code, of registrant s principal executive offices)

COMMON STOCK, PAR VALUE $.01 PER SHARE

 (Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 






 

 

 

 

 

Rule 12g-4(a)(1)

  

x

 

  

Rule 12g-4(a)(2)

  

¨

 

  

Rule 12h-3(b)(1)(i)

  

x

 

  

Rule 12h-3(b)(1)(ii)

  

¨

 

  

Rule 15d-6

  

¨

 

  

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Par Pharmaceutical Companies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 








 


 


 






Date: October 12, 2012

 


 

By:

 

/s/ Thomas J. Haughey


 


 


 

Name: Thomas J. Haughey

Title: President




Pharmacutical (NYSE:PRX)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Pharmacutical Charts.
Pharmacutical (NYSE:PRX)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Pharmacutical Charts.